Charter Life Sciences is a Mountain View, California based venture capital firm. They focus on clinical-stage investments in early-stage opportunities.
Their preferred investments are in biotechnology and drug development companies, especially in biologic and small molecule opportunities; medical device companies, especially therapeutic devices and diagnostic opportunities; and health care information technology companies, especially in companies focused on information access needs but not in consumer focused healthcare information technology.
Charter Life Sciences will invest in Series A or Series B rounds, with some later round financing, and their initial investment ranges from $1 million to $5 million and want board representation as a condition of investment.
Charter Life Sciences has made investments in WhiteLight Systems, KFx Medical, Kereos, Bullhorn, Amaranth Medical, CoMentis, Mirabilis Medica, APT Pharmaceutical, Prevacept Infection Control and Minimally invasive devices.